Adalta Ltd. has released a press release.
Oribiotech deal validates AdAlta manufacturing strategy
Earlier from Adalta
- BZDS1901 special access scheme launch in China
- EW-001 IIT study overall survival update
- 2 year survival milestone for EW-001 patient
- Oktopi AI collaboration for research efficiency